X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32287) 32287
Newsletter (3844) 3844
Publication (1790) 1790
Book Review (401) 401
Magazine Article (178) 178
Book Chapter (88) 88
Book / eBook (86) 86
Newspaper Article (61) 61
Conference Proceeding (45) 45
Web Resource (37) 37
Trade Publication Article (36) 36
Dissertation (20) 20
Journal / eJournal (8) 8
Paper (7) 7
Reference (5) 5
Data Set (2) 2
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26615) 26615
thrombolytic therapy (21636) 21636
male (14246) 14246
female (13330) 13330
middle aged (11288) 11288
aged (10441) 10441
index medicus (8255) 8255
treatment outcome (7101) 7101
cardiac & cardiovascular systems (6275) 6275
thrombolytic therapy - methods (5888) 5888
thrombolytic drugs (5783) 5783
myocardial infarction - drug therapy (5446) 5446
adult (5358) 5358
fibrinolytic agents - therapeutic use (5298) 5298
stroke (5053) 5053
time factors (4932) 4932
thrombolysis (4899) 4899
peripheral vascular disease (4781) 4781
tissue plasminogen activator - therapeutic use (4312) 4312
clinical neurology (3990) 3990
myocardial infarction - therapy (3959) 3959
aged, 80 and over (3782) 3782
risk factors (3780) 3780
care and treatment (3493) 3493
research (3210) 3210
stroke - drug therapy (3174) 3174
retrospective studies (3043) 3043
therapy (2985) 2985
mortality (2980) 2980
thrombolytic therapy - adverse effects (2781) 2781
medicine, general & internal (2755) 2755
acute myocardial-infarction (2740) 2740
fibrinolytic agents - administration & dosage (2728) 2728
prognosis (2652) 2652
myocardial infarction - mortality (2572) 2572
heart attack (2551) 2551
acute disease (2493) 2493
electrocardiography (2464) 2464
tissue plasminogen activator - administration & dosage (2371) 2371
thrombosis (2322) 2322
myocardial infarction (2295) 2295
acute ischemic-stroke (2247) 2247
prospective studies (2246) 2246
angioplasty, balloon, coronary (2223) 2223
surgery (2221) 2221
trial (2061) 2061
follow-up studies (2044) 2044
tissue-plasminogen activator (2038) 2038
management (2025) 2025
drug therapy (2010) 2010
animals (1989) 1989
myocardial infarction - physiopathology (1934) 1934
angioplasty (1881) 1881
tissue plasminogen activator (1864) 1864
anticoagulants - therapeutic use (1837) 1837
reports (1832) 1832
reperfusion (1812) 1812
ischemia (1784) 1784
myocardial infarction - diagnosis (1717) 1717
drugs (1704) 1704
brain ischemia - drug therapy (1688) 1688
stroke - therapy (1683) 1683
coronary angiography (1651) 1651
universities and colleges (1626) 1626
streptokinase - therapeutic use (1618) 1618
streptokinase (1568) 1568
hematology (1561) 1561
fibrinolytic agents - adverse effects (1535) 1535
health aspects (1500) 1500
analysis (1480) 1480
neurosciences (1470) 1470
fibrinolysis (1454) 1454
tomography, x-ray computed (1444) 1444
recurrence (1410) 1410
heart attacks (1405) 1405
cardiology (1400) 1400
thrombosis - drug therapy (1374) 1374
medical research (1371) 1371
radiology, nuclear medicine & medical imaging (1353) 1353
alteplase (1340) 1340
stents (1324) 1324
stroke - diagnosis (1267) 1267
anticoagulants (1249) 1249
pulmonary embolism (1242) 1242
combined modality therapy (1226) 1226
urokinase-type plasminogen activator - therapeutic use (1210) 1210
tissue plasminogen activator - adverse effects (1207) 1207
cardiac patients (1206) 1206
heparin - therapeutic use (1192) 1192
acute myocardial infarction (1187) 1187
randomized controlled trials as topic (1186) 1186
myocardial infarction - complications (1181) 1181
abridged index medicus (1169) 1169
medicine, experimental (1169) 1169
risk (1159) 1159
usage (1154) 1154
tissue-plasminogen-activator (1125) 1125
diagnosis (1118) 1118
infusions, intravenous (1107) 1107
neurology (1102) 1102
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (54) 54
Online Resources - Online (30) 30
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Periodical Stacks (2) 2
Scarborough Hospital - General (2) 2
Toronto East General Hospital - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (31866) 31866
German (1230) 1230
French (600) 600
Spanish (558) 558
Japanese (405) 405
Italian (371) 371
Russian (359) 359
Chinese (236) 236
Portuguese (150) 150
Polish (144) 144
Norwegian (101) 101
Danish (95) 95
Swedish (86) 86
Czech (82) 82
Turkish (65) 65
Dutch (64) 64
Hungarian (62) 62
Korean (30) 30
Finnish (26) 26
Hebrew (23) 23
Serbian (20) 20
Croatian (18) 18
Slovak (17) 17
Icelandic (8) 8
Lithuanian (6) 6
Romanian (6) 6
Ukrainian (5) 5
Persian (3) 3
Slovenian (3) 3
Bulgarian (2) 2
Arabic (1) 1
Bosnian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e669S - e690S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e1S - e23S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e576S - e600S
Background: Antithrombotic therapy in valvular disease is important to mitigate thromboembolism, but the hemorrhagic risk imposed must be considered. Methods:... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heart Valve Diseases - blood | Mitral Valve | Thrombosis - complications | Ductus Arteriosus, Patent - drug therapy | Humans | Postoperative Complications - blood | Postoperative Complications - prevention & control | Stroke - complications | Hemorrhage - prevention & control | Rheumatic Heart Disease - blood | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Ductus Arteriosus, Patent - blood | Thromboembolism - prevention & control | Aspirin - adverse effects | Heart Valve Diseases - complications | Fibrinolytic Agents - therapeutic use | Rheumatic Heart Disease - drug therapy | Rheumatic Heart Disease - complications | Aspirin - therapeutic use | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Thrombosis - blood | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Catheterization | Heart Atria | Heart Valve Prosthesis | Risk Factors | Ductus Arteriosus, Patent - complications | Combined Modality Therapy | Evidence-Based Medicine | Stroke - blood | Thromboembolism - blood | Heart Valve Diseases - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods: We... 
HIGH-RISK PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | CEREBRAL VENOUS THROMBOSIS | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | LONG-TERM SURVIVAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | ASPIRIN PLUS DIPYRIDAMOLE | NONVALVULAR ATRIAL-FIBRILLATION | EXTENDED-RELEASE DIPYRIDAMOLE | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Book
1988, ISBN 9780808918912, xii, 306
Book
1990, ISBN 0702014745, Volume 3/no. 3., x, p. 483-836.
Book
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 5, pp. 815 - 821.e6
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 9, pp. 962 - 969
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2001, Volume 357, Issue 9272, pp. 1905 - 1914
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 01/2009, Volume 40, Issue 1, pp. 140 - 146
Background and Purpose-While intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute stroke therapy within 3 hours, the... 
Vertrobrobasilary disease | Abciximab | Acute stroke | Emergency medicine | Neurocritial care | Stents | Thrombolysis | Antiplatelet agents | Interventional neuroradiology | INTRAVENOUS ABCIXIMAB | antiplatelet agents | MULTICENTER | emergency medicine | THROMBOSIS | stents | RECANALIZATION | interventional neuroradiology | vertrobrobasilary disease | CLINICAL NEUROLOGY | TRIAL | FIBRINOLYSIS | CHOICE | INFARCTION | acute stroke | neurocritial care | abciximab | DISEASE | thrombolysis | PERIPHERAL VASCULAR DISEASE | ISCHEMIC-STROKE | Infusions, Intra-Arterial - statistics & numerical data | Outcome Assessment (Health Care) - methods | Infusions, Intra-Arterial - standards | Prospective Studies | Recovery of Function - drug effects | Humans | Middle Aged | Male | Young Adult | Vertebrobasilar Insufficiency - drug therapy | Vertebrobasilar Insufficiency - mortality | Platelet Aggregation Inhibitors - administration & dosage | Thrombolytic Therapy - methods | Aged, 80 and over | Recovery of Function - physiology | Adult | Female | Thrombolytic Therapy - standards | Infusions, Intra-Arterial - methods | Basilar Artery - drug effects | Vertebrobasilar Insufficiency - pathology | Thrombolytic Therapy - statistics & numerical data | Survival Rate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Radiography | Diagnostic Imaging | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Basilar Artery - pathology | Injections, Intravenous - methods | Aged | Basilar Artery - diagnostic imaging | Fibrinolytic Agents - administration & dosage | Injections, Intravenous - standards | Injections, Intravenous - statistics & numerical data
Journal Article
2007, 1st ed., ISBN 0470319380, 350
Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute... 
Treatment | drug therapy | Heart Diseases | Fibrinolytic agents | Coronary Thrombosis | Thrombosis | therapeutic use | Thrombolytic therapy | Cardiovascular Disease | Medical / Cardiology
Book
Journal Article